Esami del sangue

Il sangue umano viene prelevato dal paziente e trasferito ad apparecchiature e analizzatori per valutarne la composizione e i fattori che indicano problemi o patologie. Spesso gli esami vengono condotti in un laboratorio di analisi, ma negli ultimi anni, grazie alla miniaturizzazione della tecnologia è possibile spostare l'attrezzatura verso il paziente, con gli analizzatori "portatili" o point of care. La valutazione delle misure effettuate, per derivarne un quadro clinico, viene fatto da un medico specializzato, che ha bisogno di valutare il complesso di più parametri e conoscere elementi essenziali sul paziente, quali l'età, il sesso, l'etnia e l'attuale stato di salute. Il solo confronto con le misure di riferimento (cosiddetti "valori di riferimento") è spesso dannoso e disinformativo.

Prelievo e conservazione
Solitamente il prelievo viene effettuato al mattino per ottenere una migliore standardizzazione e ridurre la variabilità biologica. (fonte: Wikipedia)

2015 Strategies in the Home/Self Testing Market

This new 175-page report provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation and occult blood. - Five-year sales forecasts. Competitive Assessments - Assessments of major POC suppliers and emerging market entrants. Key Topics Covered:Introduction Executive Summary Rationale for Testing Decentralization 1. Overview 2. Regulatory Trends 3. Economic Trends 4....
01/07/2015 16:42

2015 Strategies in the US Home/Self Testing Market

This new 175-page report provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation and occult blood. - Five-year sales forecasts.
26/06/2015 18:28

NIFTY™ Becomes First CFDA Approved Non-Invasive Prenatal Genetic Test

On June 30, 2014, the CFDA approved the registration of BGI's BGISEQ-1000 and BGISEQ-100 sequencers, and its prenatal genetic testing kits for NIFTY™ (Non-Invasive Fetal Trisomy test). This is the first genetic test based on next generation sequencing technology to be approved by the CFDA and makes the NIFTY™ test the only certified non-invasive prenatal test currently available in China.
07/07/2014 09:59

Point of Care Diagnostic Testing: World Markets Report 2013

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Point of Care Diagnostic Testing World Markets 2013 describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the...
01/10/2013 18:14
  • 1 (current)
  • 2
Loading....